Most patients on ciclosporin for moderate-to severe psoriasis are discontinuing the drug within months due to lack of efficacy and moving onto biologics. A review of ciclosporin use from 851 patients in the Australasian Psoriasis Registry found 62.8% of patients ceased using the drug due to lack of efficacy and 37.8% due to toxicity. Those ...
Real world data confirms ciclosporin is only used short-term for psoriasis
By Mardi Chapman
18 May 2020